LYZZ Capital is a global healthcare-focused venture capital/private equity firm investing in talents, assets, and technologies globally, with a strong focus on addressing unmet medical needs and leveraging China’s large market potential. The firm combines experienced professionals from leading pharmaceutical/biotech companies and Wall Street, with over 20 years of combined biotech investment experience, including 15 years in China.
Bevorzugte Reifephase für die erste Finanzierung.
Global healthcare investments with emphasis on unmet medical needs and large market potential in China
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...